The Institute for Safe Medication Practices has made available a new tool to help hospitals, long-term care facilities, and some outpatient facilities evaluate and monitor best practices for the distribution of high-alert medications. The ISMP Medication Safety Self Assessment® for High-Alert Medications focuses on systems and practices associated with 11 categories of high-alert medications which are defined as drugs that carry a heightened risk of causing significant patient harm when an error occurs. Those categories include: opioids, insulin, neuromuscular blocking agents, chemotherapy, and moderate and minimal sedation.
ISMP’s assessment tool aids in identifying opportunities for improvement and monitoring progress over time. Participating facilities are encouraged to submit their findings anonymously using a secure online portal in order to be able to compare their standings to demographically similar organizations. Participation also can help facilities meet medication management requirements set forth by regulatory and accrediting agencies like the Centers for Medicare & Medicaid Services and The Joint Commission.
To learn more about the ISMP Medication Safety Self Assessment® for High-Alert Medications, click here.
Get PSO News Via Email
Read Our Free PSO WhitepaperLearn how PSOs can help you build a safer, smarter organization without the fear of legal liability. Read our FREE whitepaper, "Patient Safety Organizations: Gaining Better Insight Without the Fear of Legal Discovery," authored in conjunction with Lynda M. Johnson, partner at Friday Eldredge & Clark, LLP.